Literature DB >> 10738297

Genetics of Beckwith-Wiedemann syndrome-associated tumors: common genetic pathways.

M Steenman1, A Westerveld, M Mannens.   

Abstract

A specific subset of solid childhood tumors-Wilms' tumor, adrenocortical carcinoma, rhabdomyosarcoma, and hepatoblastoma-is characterized by its association with Beckwith-Wiedemann syndrome. Genetic abnormalities found in these tumors affect the same chromosome region (11p15), which has been implicated in the etiology of Beckwith-Wiedemann syndrome. This suggests that the development of these tumors occurs along a common genetic pathway involving chromosome 11. To search for additional common genetic pathways, this article reviews the genetic data published for these tumors. It was found that, up until now, the only genetic abnormalities detected in all four tumors affect chromosome band 11p15 and the TP53 gene. In addition, there are several aberrations that occur in two or three of the neoplasms. It is concluded that, of the four tumors, the genetic relationship is most evident between Wilms' tumor and rhabdomyosarcoma. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10738297     DOI: 10.1002/(sici)1098-2264(200005)28:1<1::aid-gcc1>3.0.co;2-#

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

Review 1.  Discerning malignancy in resected adrenocortical neoplasms.

Authors:  H Sasano; T Suzuki; T Moriya
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

2.  Altered microRNA Expression Patterns in Hepatoblastoma Patients.

Authors:  Armando Magrelli; Gianluca Azzalin; Marco Salvatore; Mara Viganotti; Fabrizio Tosto; Teresa Colombo; Rita Devito; Alessandra Di Masi; Antonio Antoccia; Stefano Lorenzetti; Francesca Maranghi; Alberto Mantovani; Caterina Tanzarella; Giuseppe Macino; Domenica Taruscio
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

Review 3.  Clinical relevance of molecular genetics to paediatric sarcomas.

Authors:  Olga Slater; Janet Shipley
Journal:  J Clin Pathol       Date:  2007-04-27       Impact factor: 3.411

Review 4.  Pediatric Rhabdomyosarcoma.

Authors:  Jack F Shern; Marielle E Yohe; Javed Khan
Journal:  Crit Rev Oncog       Date:  2015

Review 5.  Optimal management strategies for rhabdomyosarcoma in children.

Authors:  David Walterhouse; Andrea Watson
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 6.  A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer.

Authors:  Mark J Hoenerhoff; Hue Hua Hong; Tai-vu Ton; Stephanie A Lahousse; Robert C Sills
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

7.  Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.

Authors:  Simone Hettmer; Natasha M Archer; Gino R Somers; Ana Novokmet; Amy J Wagers; Lisa Diller; Carlos Rodriguez-Galindo; Lisa A Teot; David Malkin
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

8.  Hidden chromosomal abnormalities in pleuropulmonary blastomas identified by multiplex FISH.

Authors:  Benoit Quilichini; Nicolas Andre; Corinne Bouvier; Marie-Anne Chrestian; Angelique Rome; Dominique Intagliata; Carole Coze; Gabriel Lena; Helene Zattara
Journal:  BMC Cancer       Date:  2006-01-05       Impact factor: 4.430

Review 9.  The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials.

Authors:  Daniel C Aronson; Piotr Czauderna; Rudolf Maibach; Giorgio Perilongo; Bruce Morland
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-10

10.  Genomic landscape of paediatric adrenocortical tumours.

Authors:  Emilia M Pinto; Xiang Chen; John Easton; David Finkelstein; Zhifa Liu; Stanley Pounds; Carlos Rodriguez-Galindo; Troy C Lund; Elaine R Mardis; Richard K Wilson; Kristy Boggs; Donald Yergeau; Jinjun Cheng; Heather L Mulder; Jayanthi Manne; Jesse Jenkins; Maria J Mastellaro; Bonald C Figueiredo; Michael A Dyer; Alberto Pappo; Jinghui Zhang; James R Downing; Raul C Ribeiro; Gerard P Zambetti
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.